Sen. Bernie Sanders demands the resignation of HHS Secretary Robert F. Kennedy Jr. following chaos at the CDC, criticizing his anti-vaccine stance and calling for accountability in public health leadership.
In a surprising turn of events, Jim O'Neill has been appointed as the interim director of the CDC following a high-profile dispute involving former director Susan Monarez. What does this mean for public health?
The CDC faces turmoil after the firing of its director, as HHS Secretary Robert F. Kennedy Jr. highlights urgent reforms needed. Agency employees express concerns over vaccine safety and decision-making.
A shocking report reveals the first human case of the New World screwworm in the U.S., raising alarms in the livestock industry. The CDC confirmed the case in Maryland linked to travel from El Salvador.
The AAP's new recommendations for pediatric COVID-19 vaccines clash with CDC guidance, prompting HHS Secretary Kennedy to issue a warning about potential liability for physicians. Experts respond.
In a surprising move, the Trump administration, under Robert F. Kennedy Jr., has canceled over $500 million in funding for mRNA vaccine development, raising alarms about America's future public health preparedness. Experts warn this could lead to dangerous vulnerabilities against infectious diseases.
HHS Secretary Robert F. Kennedy Jr. has sparked outrage by canceling $500 million in mRNA vaccine research grants, citing questionable data. Experts warn this could hinder public health efforts and the future of vaccine technology.
Health Secretary Robert F. Kennedy Jr.'s drastic funding cuts to mRNA vaccine research could stymie medical breakthroughs and push scientific talent away from the U.S., experts warn.
Dr. Vinay Prasad is back at the FDA's Center for Biologics Evaluation and Research, raising eyebrows after being ousted amid political turmoil and criticism. His return ignites debates about drug approvals and public health leadership under the Trump administration.
In a surprising move, U.S. health officials have canceled $500 million in mRNA vaccine research, citing studies that question their safety and effectiveness. Critics warn this decision undermines vital public health advancements made during the pandemic.
